StonvexLoading…
StonvexCore line items from PKOH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2026 (Est.) Expected 2026-11-02 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $444.31M | $421.00M | $1.60B | $1.20B | $805.50M |
Operating Income | Not available | $19.70M | $66.30M | $56.30M | $39.00M |
Net Income | Not available | $8.10M | $23.80M | $22.80M | $17.50M |
EPS (Diluted) | $0.89 | $0.57 | $1.70 | $1.63 | $1.26 |
Total Assets | Not available | $1.44B | $1.42B | $1.44B | $1.42B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $46.70M | $44.80M | $50.80M | $45.60M |
Free Cash Flow OCF − CapEx | Not available | $-20.30M | $2.00M | $-34.00M | $-40.60M |
Shares Outstanding | Not available | 14.10M | 13.97M | 14.00M | 13.90M |